Switch to:
Denali Therapeutics Inc  (NAS:DNLI) Median PS Value: $675.73 (As of Today)

This valuation method assumes that the stock valuation will revert to its historical mean in terms of Price/Sales Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because Price/Sales Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median P/S Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median P/S ratio. Denali Therapeutics Inc's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2019 was $1.407. Denali Therapeutics Inc's 10-Year median P/S ratio is 480.27. Therefore, the Median P/S Value for today is $675.73.

As of today, Denali Therapeutics Inc's share price is $19.55. Denali Therapeutics Inc's median P/S value is $675.73. Therefore, Denali Therapeutics Inc's Price to Median P/S Value Ratio for today is 0.03.

NAS:DNLI' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.02   Max: 5.58
Current: 0.03

0.02
5.58

During the past 4 years, the highest Price to Median P/S Value Ratio of Denali Therapeutics Inc was 5.58. The lowest was 0.02. And the median was 1.13.

NAS:DNLI's Price-to-Median-PS-Value is ranked higher than
90% of the 678 Companies
in the Global industry.

( Industry Median: 0.92 vs. NAS:DNLI: 0.03 )

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Denali Therapeutics Inc Annual Data

Dec15 Dec16 Dec17 Dec18
Median PS Value 0.00 0.00 0.00 657.96

Denali Therapeutics Inc Quarterly Data

Dec15 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19
Median PS Value Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.36 12.01 18.25 657.96 675.73

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Denali Therapeutics Inc Distribution

* The bar in red indicates where Denali Therapeutics Inc's Median PS Value falls into.



Calculation

Denali Therapeutics Inc's Median P/S Value for today is calculated as

Median P/S Value=Total Annual Sales / Shares Outstanding*10-Year Median P/S Ratio
=Revenue per Share (TTM)*10-Year Median P/S Ratio
=1.407*480.27
=675.74

10-Year Median P/S Ratio is 480.27.
Denali Therapeutics Inc's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2019 was 0.018 (Jun. 2018 ) + 0.013 (Sep. 2018 ) + 1.332 (Dec. 2018 ) + 0.044 (Mar. 2019 ) = $1.407.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Explanation

This valuation method assumes that the stock valuation will revert to its historical mean in terms of Price/Sales Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because Price/Sales Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Denali Therapeutics Inc's Price to Median P/S Value Ratio for today is calculated as

Price to Median P/S Value=Share Price/Median P/S Value
=19.55/675.74
=0.03

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Related Terms


Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK